-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

First Generation vs. Second Generation TKI - Which is Best At Diagnosis of Chronic Phase CML?

Program: Education Program
Session: Handling Challenging Questions in the Management of CML
Saturday, December 5, 2020, 11:55 AM-12:00 PM

Vivian G. Oehler, MD

Fred Hutchinson Cancer Research Ctr., Seattle, WA

Disclosures: Oehler: Takeda: Consultancy; BMS: Consultancy; Pfizer, Inc: Research Funding.

See more of: Handling Challenging Questions in the Management of CML
See more of: Education Program
Previous Presentation | Next Presentation >>